MCQOPTIONS
Saved Bookmarks
| 1. |
Which Indian institute will begin the Phase II/III trial of VPM1002 vaccine for TB in June 2017? |
| A. | Serum Institute of India Ltd |
| B. | Panacea Biotec Ltd |
| C. | Bharat Biotech International Ltd |
| D. | Central Drug Research Institute |
| Answer» B. Panacea Biotec Ltd | |